Anika Therapeutics Inc
SWB:AKP
Anika Therapeutics Inc
SWB:AKP
Price:
12.5
EUR
-2.34%
Market Closed
Market Cap:
€297.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Anika Therapeutics Inc
SWB:AKP
|
US |
|
M
|
MSCI Inc
F:3HM
|
US |
|
A
|
Air Products and Chemicals Inc
DUS:AP3
|
US |
|
A
|
Air Products and Chemicals Inc
F:AP3
|
US |
|
H
|
Hyatt Hotels Corp
F:1HTA
|
US |
|
D
|
Discover Financial Services
DUS:DC7
|
US |
|
P
|
PNC Financial Services Group Inc
F:PNP
|
US |
|
P
|
PepsiCo Inc
SWB:PEP
|
US |
|
E
|
Evolution AB (publ)
F:E3G
|
SE |
|
K
|
Kimco Realty Corp
F:KIC
|
US |
|
O
|
ON Semiconductor Corp
XMUN:XS4
|
US |
|
B
|
Berkshire Hathaway Inc
XMUN:BRYN
|
US |
|
P
|
Pagegroup PLC
F:3MI
|
UK |
Wall St Price Targets
AKP Price Targets Summary
Anika Therapeutics Inc
Anika Therapeutics Inc
Wall Street analysts forecast AKP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for AKP is 14.98 EUR with a low forecast of 14.41 EUR and a high forecast of 15.87 EUR.
Lowest Forecast
Price Target
14.41
EUR
15% Upside
Average Forecast
Price Target
14.98
EUR
20% Upside
Highest Forecast
Price Target
15.87
EUR
27% Upside
Anika Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKP's stock price target?
Price Target
14.98
EUR
14.98
EUR
According to Wall Street analysts, the average 1-year price target for AKP is 14.98 EUR with a low forecast of 14.41 EUR and a high forecast of 15.87 EUR.
What is the Revenue forecast for Anika Therapeutics Inc?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 7%.
